These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of SOD, catalase, and a novel antiarrhythmic drug, EGB 761, on reperfusion-induced arrhythmias in isolated rat hearts. Tosaki A, Droy-Lefaix MT, Pali T, Das DK. Free Radic Biol Med; 1993 Apr; 14(4):361-70. PubMed ID: 8385645 [Abstract] [Full Text] [Related]
4. Carvedilol improves function and reduces infarct size in the feline myocardium by protecting against lethal reperfusion injury. Brunvand H, Frłyland L, Hexeberg E, Rynning SE, Berge RK, Grong K. Eur J Pharmacol; 1996 Oct 24; 314(1-2):99-107. PubMed ID: 8957224 [Abstract] [Full Text] [Related]
5. Chronic treatment with propranolol induces antioxidant changes and protects against ischemia-reperfusion injury. Khaper N, Rigatto C, Seneviratne C, Li T, Singal PK. J Mol Cell Cardiol; 1997 Dec 24; 29(12):3335-44. PubMed ID: 9441839 [Abstract] [Full Text] [Related]
6. Effect of carvedilol on atrioventricular conduction in the ischemic heart. Horio T, Ito S, Aoyama M, Takeda Y, Suzumura H, Nakata K, Yamada Y, Suzuki S, Fukutomi T, Itoh M. Eur J Pharmacol; 2001 Jan 26; 412(2):145-53. PubMed ID: 11165226 [Abstract] [Full Text] [Related]
13. Neuroprotective effect of carvedilol against aluminium induced toxicity: possible behavioral and biochemical alterations in rats. Kumar A, Prakash A, Dogra S. Pharmacol Rep; 2011 Jan 26; 63(4):915-23. PubMed ID: 22001979 [Abstract] [Full Text] [Related]
15. Norepinephrine-induced changes in rat heart function, metabolism, and weight are antagonized by carvedilol. Nagano T, O'Harrow S, Sponer G, Zimmer HG. J Cardiovasc Pharmacol; 1993 Apr 26; 21(4):530-6. PubMed ID: 7681896 [Abstract] [Full Text] [Related]
16. Cardioprotection by Carvedilol: antiapoptosis is independent of beta-adrenoceptor blockage in the rat heart. Schwarz ER, Kersting PH, Reffelmann T, Meven DA, Al-Dashti R, Skobel EC, Klosterhalfen B, Hanrath P. J Cardiovasc Pharmacol Ther; 2003 Sep 26; 8(3):207-15. PubMed ID: 14506546 [Abstract] [Full Text] [Related]
17. Dose-effect and pharmacokinetic-pharmacodynamic relationships of the beta 1-adrenergic receptor blocking properties of various doses of carvedilol in healthy humans. de Mey C, Breithaupt K, Schloos J, Neugebauer G, Palm D, Belz GG. Clin Pharmacol Ther; 1994 Mar 26; 55(3):329-37. PubMed ID: 7908256 [Abstract] [Full Text] [Related]
18. Electrophysiologic effects of carvedilol: is carvedilol an antiarrhythmic agent? El-Sherif N, Turitto G. Pacing Clin Electrophysiol; 2005 Sep 26; 28(9):985-90. PubMed ID: 16176541 [Abstract] [Full Text] [Related]
19. Carvedilol and antioxidant proteins in a type I diabetes animal model. Diogo CV, Deus CM, Lebiedzinska-Arciszewska M, Wojtala A, Wieckowski MR, Oliveira PJ. Eur J Clin Invest; 2017 Jan 26; 47(1):19-29. PubMed ID: 27805735 [Abstract] [Full Text] [Related]
20. Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol. Van den Branden C, Gabriels M, Vamecq J, Vanden Houte K, Verbeelen D. Nephron; 1997 Jan 26; 77(3):319-24. PubMed ID: 9375827 [Abstract] [Full Text] [Related] Page: [Next] [New Search]